NO975127L - Anvendelse av ikke-steroidale antiinflammatoriske midler for å forbedre den fysiologiske forlikelighet av partikulære farmasöytiske preparater - Google Patents

Anvendelse av ikke-steroidale antiinflammatoriske midler for å forbedre den fysiologiske forlikelighet av partikulære farmasöytiske preparater

Info

Publication number
NO975127L
NO975127L NO975127A NO975127A NO975127L NO 975127 L NO975127 L NO 975127L NO 975127 A NO975127 A NO 975127A NO 975127 A NO975127 A NO 975127A NO 975127 L NO975127 L NO 975127L
Authority
NO
Norway
Prior art keywords
inflammatory agents
steroidal anti
pharmaceutical preparations
improve
particulate pharmaceutical
Prior art date
Application number
NO975127A
Other languages
English (en)
Other versions
NO975127D0 (no
Inventor
Werner Krause
Peter Muschick
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7762219&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO975127(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO975127D0 publication Critical patent/NO975127D0/no
Publication of NO975127L publication Critical patent/NO975127L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Anvendelse av ikke-steroidale antiinflammatoriske midler som additi- ver i partikulære farmasøytiske prepa- rater kan redusere forekomsten av bi- virkninger på det kardiovaskulære system når preparatene administreres.
NO975127A 1995-05-10 1997-11-07 Anvendelse av ikke-steroidale antiinflammatoriske midler for å forbedre den fysiologiske forlikelighet av partikulære farmasöytiske preparater NO975127L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19518221A DE19518221A1 (de) 1995-05-10 1995-05-10 Verwendung nichtsteroidaler Entzündungshemmer zur Verbesserung der physiologischen Verträglichkeit partikulärer pharmazeutischer Zubereitungen
PCT/EP1996/001936 WO1996035429A1 (de) 1995-05-10 1996-05-09 Verwendung nichtsteroidaler entzündungshemmer zur verbesserung der physiologischen verträglichkeit partikulärer pharmazeutischer zubereitungen

Publications (2)

Publication Number Publication Date
NO975127D0 NO975127D0 (no) 1997-11-07
NO975127L true NO975127L (no) 1997-12-10

Family

ID=7762219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975127A NO975127L (no) 1995-05-10 1997-11-07 Anvendelse av ikke-steroidale antiinflammatoriske midler for å forbedre den fysiologiske forlikelighet av partikulære farmasöytiske preparater

Country Status (7)

Country Link
US (1) US5874422A (no)
EP (1) EP0831840A1 (no)
JP (1) JPH11504930A (no)
CA (1) CA2220052A1 (no)
DE (1) DE19518221A1 (no)
NO (1) NO975127L (no)
WO (1) WO1996035429A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
IL113926A (en) * 1995-05-31 2000-06-01 Korenstein Rafi Contrast medium with improved patient's tolerance thereto and its use
DE19721947C2 (de) * 1997-05-21 1999-04-22 Diagnostikforschung Inst Verwendung von pharmazeutischen Zubereitungen, die Partikel, Vesikel oder Polymere sowie nichtsteroidale Antirheumatika und/oder Thrombozytenaggregationshemmer zur Darstellung der Gefäße, Lymphknoten und des Knochenmarks enthalten
EP1031347B1 (en) 1999-01-27 2002-04-17 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
DE69901377T2 (de) 1999-01-27 2003-01-02 Idea Ag Nichtinvasive Impfung durch die Haut
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
US20050191357A1 (en) * 2002-03-20 2005-09-01 Yoshiaki Kawashima Method of manufacturing chemical-containing composite particles
RU2005112247A (ru) * 2002-09-25 2006-01-20 Форбз Меди-Тек Инк. (Ca) Новые структуры и композиции, содержащие стеролы и/или станолы и определенные классы противовоспалительных средств, и их применение для лечения или предупреждения сердечно-сосудистого заболевания, лежащих в его основе состояний, включая гиперлипидемию, и других нарушений, при которых воспаление является частью их этиологии или проявления
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
CA2584475A1 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672733A5 (no) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents

Also Published As

Publication number Publication date
WO1996035429A1 (de) 1996-11-14
CA2220052A1 (en) 1996-11-14
NO975127D0 (no) 1997-11-07
EP0831840A1 (de) 1998-04-01
DE19518221A1 (de) 1996-11-14
US5874422A (en) 1999-02-23
JPH11504930A (ja) 1999-05-11

Similar Documents

Publication Publication Date Title
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
NO934284D0 (no) Farmas!ytisk preparat inneholdende et definert lipidsystem
CA2239174A1 (en) Novel compounds with analgesic effect
DE69710065D1 (de) Androsten-derivate
AR012376A1 (es) Formulacion de gel para la aplicacion topica
MX21452A (es) Preparaciones farmaceuticas que se administran en forma topica.
IE831611L (en) Topical anti-inflammatory compositions
NO954878L (no) Pyrrolderivater
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
SE9602442D0 (sv) Administration of pharmaceuticals
NO975127L (no) Anvendelse av ikke-steroidale antiinflammatoriske midler for å forbedre den fysiologiske forlikelighet av partikulære farmasöytiske preparater
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
FR2754177B1 (fr) Microspheres pharmaceutiques d'acide valproique pour administration orale
SE9402880D0 (sv) New peptide derivatives
DE69102704D1 (de) Orales, melatonin enthaltendes arzneimittel.
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
NO980296D0 (no) Forbedrede terapeutiske midler
IT1255076B (it) Microsfere biodegradabili ad uso farmaceutico e cosmetico
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
MX21453A (es) Preparaciones farmaceuticas que se administran en forma topica.
ATE253923T1 (de) Verhütung von magen-darm schäden
TR199900013T2 (xx) Yeni bile�ikler.
IT1265342B1 (it) Composizioni farmaceutiche a base di derivati della glicina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application